FDA Clearance Tracker · P030017-S357
Precision, Precision Spectra, Precision Novi, Precision Montage, Precision Montage MRI, Spectra WaveWriter, WaveWriter A
Last checked: Nov 20, 2026Latest source record: Oct 5, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Oct 5, 2023
Approved
Time to decision
281 days
Received Dec 28, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P030017-S357
- Device name
- Precision, Precision Spectra, Precision Novi, Precision Montage, Precision Montage MRI, Spectra WaveWriter, WaveWriter A
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Dec 28, 2022
- Decided
- Oct 5, 2023
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P030017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for expanding the indications to include diabetic peripheral neuropathy (DPN) of the lower extremities for paresthesia-based stimulation.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.